Hologic | HOLX - Cash And Equivalent


Hologic reported $2.17B in Cash and Equivalent for its fiscal quarter ending in December of 2025.





Cash And Equivalent Change Date
Abbott USD 8.52B 1.01B Dec/2025
Agilent USD 1.76B 31M Dec/2025
Becton, Dickinson and Co. USD 740M 99M Dec/2025
Bio Techne USD 172.88M 27.92M Dec/2025
Bio-Rad Laboratories USD 529.8M 134M Dec/2025
Boston Scientific USD 1.96B 690M Dec/2025
Bruker USD 293.1M 201.1M Sep/2025
Charles River Laboratories USD 213.77M 6.67M Dec/2025
Cooper Companies USD 110.6M 14.3M Sep/2025
Danaher USD 4.62B 3.09B Dec/2025
Dexcom USD 917.7M 918M Dec/2025
Edwards Lifesciences USD 2.69B 587.2M Sep/2025
Fuji Electric JPY 69.37B 14.31B Dec/2025
Fujifilm JPY 160.88B 906M Sep/2025
General Electric Aerospace USD 12.39B 109M Dec/2025
Globus Medical USD 526.16M 154.39M Dec/2025
Hologic USD 2.17B 208.5M Dec/2025
Illumina USD 1.42B 368M Dec/2025
Insulet USD 716.1M 41.3M Dec/2025
Integra LifeSciences USD 235.05M 2.86M Dec/2025
Intuitive Surgical USD 9.03B 601.6M Dec/2025
IQVIA Holdings USD 1.98B 166M Dec/2025
Medtronic USD 1.15B 135M Dec/2025
Mettler Toledo International USD 69.06M 7.24M Sep/2025
OraSure Technologies USD 199.28M 17.2M Dec/2025
Philips EUR 1.91B 90M Sep/2025
Quidel USD 169.8M 71.7M Dec/2025
Revvity USD 919.86M 11.53M Dec/2025
Roche Holding CHF 7.55B 579M Jun/2025
Siemens EUR 14.5B 146M Sep/2025
Stryker USD 4.01B 755M Dec/2025
Teleflex USD 354M 100.3M Sep/2025
Thermo Fisher Scientific USD 9.85B 7.87B Dec/2025
Waters USD 587.83M 128.71M Dec/2025
Zimmer Biomet Holdings USD 591.9M 700.8M Dec/2025